InflaRx NV Correlations
IFRX Stock | USD 2.36 0.05 2.16% |
The current 90-days correlation between InflaRx NV and Generation Bio Co is -0.06 (i.e., Good diversification). The correlation of InflaRx NV is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
InflaRx NV Correlation With Market
Significant diversification
The correlation between InflaRx NV and DJI is 0.06 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding InflaRx NV and DJI in the same portfolio, assuming nothing else is changed.
InflaRx |
Moving together with InflaRx Stock
0.86 | DYAI | Dyadic International | PairCorr |
0.84 | ESPR | Esperion Therapeutics | PairCorr |
0.75 | BMY | Bristol Myers Squibb | PairCorr |
0.61 | MNMD | Mind Medicine | PairCorr |
0.62 | ABCL | Abcellera Biologics | PairCorr |
Moving against InflaRx Stock
0.92 | ERNA | Eterna Therapeutics | PairCorr |
0.91 | VALN | Valneva SE ADR | PairCorr |
0.8 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.8 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
0.72 | GNFT | Genfit | PairCorr |
0.66 | LLY | Eli Lilly | PairCorr |
0.6 | SLS | Sellas Life Sciences | PairCorr |
0.57 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.54 | IMAB | I Mab | PairCorr |
0.51 | INBX | Inhibrx Symbol Change | PairCorr |
0.91 | AMGN | Amgen Inc | PairCorr |
0.76 | MRVI | Maravai Lifesciences | PairCorr |
0.75 | REGN | Regeneron Pharmaceuticals | PairCorr |
0.71 | RANI | Rani Therapeutics | PairCorr |
0.66 | ABBV | AbbVie Inc | PairCorr |
0.65 | SXTPW | 60 Degrees Pharmaceu | PairCorr |
0.65 | MBIO | Mustang Bio | PairCorr |
0.55 | ABOS | Acumen Pharmaceuticals | PairCorr |
0.54 | AKAN | Akanda Corp | PairCorr |
0.45 | INKT | Mink Therapeutics | PairCorr |
0.37 | NUVL | Nuvalent | PairCorr |
0.91 | TFFP | Tff Pharmaceuticals | PairCorr |
0.81 | AVDL | Avadel Pharmaceuticals | PairCorr |
0.75 | TCRX | Tscan Therapeutics | PairCorr |
0.73 | APGE | Apogee Therapeutics, | PairCorr |
0.69 | TTOO | T2 Biosystms | PairCorr |
0.65 | AQST | Aquestive Therapeutics | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between InflaRx Stock performing well and InflaRx NV Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze InflaRx NV's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
GBIO | 3.85 | (1.40) | 0.00 | (0.29) | 0.00 | 6.36 | 21.16 | |||
KRON | 2.90 | 0.13 | 0.01 | (9.16) | 3.54 | 5.75 | 17.56 | |||
ERAS | 3.40 | (0.37) | 0.00 | (0.10) | 0.00 | 7.42 | 20.29 | |||
CCCC | 3.66 | (0.53) | 0.00 | (0.64) | 0.00 | 9.28 | 23.66 | |||
EWTX | 3.49 | 0.62 | 0.22 | 0.29 | 3.10 | 6.65 | 61.90 | |||
KZR | 2.84 | 0.33 | 0.11 | 0.42 | 2.60 | 4.93 | 51.13 | |||
FULC | 3.50 | 0.20 | 0.05 | 0.25 | 3.69 | 9.43 | 24.61 | |||
PASG | 6.36 | 0.21 | 0.05 | 0.15 | 6.70 | 12.07 | 84.39 | |||
ABOS | 3.42 | (0.40) | 0.00 | (0.08) | 0.00 | 6.70 | 28.07 | |||
GRTX | 2.93 | 0.02 | 0.00 | 0.05 | 0.00 | 7.31 | 18.16 |
InflaRx NV Corporate Management
Jan CFA | Head VP | Profile | |
Thomas Taapken | Chief Officer | Profile | |
Derval OCarroll | Senior Compliance | Profile | |
Igor Orshanskiy | Senior Development | Profile | |
Maria Habel | Head RD | Profile | |
Christian Schmid | VP Counsel | Profile | |
Kofi Boaten | Senior Supplies | Profile |